Patents/Assignees

GENOIMMUNE THERAPEUTICS CO., Ltd.

4 patents in portfolio

US12453774utility2025
Tumor Immunotherapy Polypeptide and Application Thereof
0 cites
US11834516utility2023
Tumor-specific Polypeptide and Use Thereof
0 cites
US11612643utility2023
Col14a1-derived Tumor Antigen Polypeptide and Use Thereof
0 cites
US11548925utility2023
Cacna1h-derived Tumor Antigen Polypeptide and Use Thereof
0 cites